Medical Devices Philippines

Philippines Over-the-Counter CGM Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Philippines Over-the-Counter CGM Market Industry Trends and Forecast to 2034: Segmented by (Product, User, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Philippines · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $0.5 Mn Placeholder estimate
Estimate 2025 $0.7 Mn 0.3% of the global market
Projected 2034 $11.4 Mn 1,450% Adds $10.7 Mn over 9 forecast years
CAGR 2025–2034 35.6% Faster than 100% of 173 Medical Devices markets here
Key players 5
  • Philippines is 0.27% of the global market.
  • In APAC, the largest is China at $22.8 Mn.
  • Fastest growing: India at 37.7% a year.
  • Philippines ranks 6th of 10 by size in APAC.

Market size projection

Philippines

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$10.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Over-the-Counter CGM Market market size by year, Philippines
YearMarket sizeChange that yearSince 2025
2024 (estimate) $0.5 Mn — —
2025 (base) $0.7 Mn +$0.2 Mn —
2026 (forecast) $1.0 Mn +$0.3 Mn +35.6%
2027 (forecast) $1.4 Mn +$0.4 Mn +83.9%
2028 (forecast) $1.8 Mn +$0.5 Mn +149.3%
2029 (forecast) $2.5 Mn +$0.7 Mn +238.1%
2030 (forecast) $3.4 Mn +$0.9 Mn +358.5%
2031 (forecast) $4.6 Mn +$1.2 Mn +521.7%
2032 (forecast) $6.2 Mn +$1.6 Mn +743%
2033 (forecast) $8.4 Mn +$2.2 Mn +1,043.1%
2034 (forecast) $11.4 Mn +$3.0 Mn +1,450%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Philippines Over-the-Counter CGM Market Analysis at a glance
Market size, 2025$0.7 Mn placeholder estimate
Forecast, 2034$11.4 Mn placeholder estimate
Growth (CAGR), 2025–203435.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, user and end user (see all)
Key playersDexcom, Inc., Abbott Laboratories, Levels Health, Nutrisense, Signos (see all)
Regulator in the PhilippinesFDA PhilippinesSource: Food and Drug Administration Philippines. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Philippines Over-the-Counter CGM Market Analysis Executive Summary

Over-the-counter continuous glucose monitors are sensors sold without a prescription to adults who want to see how food and activity affect their blood sugar.

Key segments of the over-the-Counter CGM market include product (Biosensors and Mobile Apps and Subscriptions) and user (Non-Insulin Type 2 Diabetes, Prediabetes and Wellness Users).

Bar chart: Philippines Over-the-Counter CGM market size, 2024–2034, placeholder estimates. $0.5 Mn in 2024, $0.7 Mn in 2025 and $11.4 Mn in 2034, 35.6% CAGR.
Philippines Over-the-Counter CGM market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Philippines Over-the-Counter CGM Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the over-the-Counter CGM market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the over-the-Counter CGM market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the over-the-Counter CGM market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Over-the-Counter CGM Market in Philippines

The over-the-Counter CGM market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Over-the-Counter CGM Market in Philippines

Over-the-Counter CGM in the Philippines: rules, payment and health figures

Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA).⁠[1] PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.⁠[2] Diabetes (adults): 13.2% of adults in 2022, the latest WHO figure for the Philippines.⁠[3]

[1] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[2] PhilHealth. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how over-the-Counter CGM products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Philippines.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Over-the-Counter CGM right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Over-the-Counter CGM in context

The Philippines compared

  • Diabetes (adults, WHO): 13.2% of adults (2022). World: 14.1% of adults (2022). 8th highest of the 15 countries we cover in APAC.[1]
  • Health spending per person: 194 US$ per person (2023). World: 1,317 US$ per person (2023). 8th highest of the 15 countries we cover in APAC.[2]
  • Doctors: 0.79 per 1,000 people (2021). World: 1.86 per 1,000 people (2022). 9th highest of the 15 countries we cover in APAC.[3]

[1] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 18 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Over-the-Counter CGM market in the Philippines?
Placeholder estimate: about $0.7 Mn in 2025, rising to about $11.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Over-the-Counter CGM market in the Philippines growing?
Placeholder estimate: about 35.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Over-the-Counter CGM market report cover?
The report splits the market by product (Biosensors, Mobile Apps and Subscriptions), user (Non-Insulin Type 2 Diabetes, Prediabetes, Wellness Users) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Over-the-Counter CGM market?
Key players include Dexcom, Inc., Abbott Laboratories, Levels Health, Nutrisense and Signos.
What is driving the Over-the-Counter CGM market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the over-the-Counter CGM market.
Who regulates Over-the-Counter CGM in the Philippines?
Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA). Source: Food and Drug Administration Philippines. Checked 14 Nov 2026.
How is healthcare paid for in the Philippines?
PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member. Source: PhilHealth. Checked 14 Nov 2026.
What does WHO report for the Philippines?
Diabetes (adults): 13.2% of adults in 2022, the latest WHO figure. Source: WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 15 Nov 2026.
How many people in the Philippines are 65 or older?
5.7% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 18 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Philippines

See all

Related on diabetes and fitness

See the topic